BANCA MEDIOLANUM SPA (BMED.MI) Forecast, Price Target & Analyst Ratings
BIT:BMED • IT0004776628
17.295 EUR
+0.68 (+4.06%)
Last: Mar 10, 2026, 10:12 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BANCA MEDIOLANUM SPA (BMED.MI).
Forecast Snapshot
Consensus Price Target
€21.94
+ 26.86% Upside
Next Earnings Forecast
Release DateMay 7, 2026
PeriodQ1 / 2026
EPS Estimate€0.35
Revenue Estimate
ChartMill Buy Consensus
78.82%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€21.94
Upside
+ 26.86%
From current price of €17.30 to mean target of €21.94, Based on 17 analyst forecasts
Low
€20.60
Median
€22.03
High
€23.94
Price Target Revisions
1 Month
3.76%
3 Months
9.85%
Price Target Summary
17 Wall Street analysts provided a forecast for the next 12 months for BMED.MI. The average price target is 21.94 EUR. This implies a price increase of 26.86% is expected in the next year compared to the current price of 17.295.
The average price target has been revised upward by 9.85% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.82%
BMED.MI was analyzed by 17 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about BMED.MI.
In the previous month the buy percentage consensus was at a similar level.
BMED.MI was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-26 | INTESA SANPAOLO EQUITY RESEARCH | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 7, 2026
PeriodQ1 / 2026
EPS Estimate€0.35
Revenue EstimateN/A
Revenue Q2QN/A
EPS Q2QN/A
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
BMED.MI is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 0.35 EUR and the consensus revenue estimate is null EUR.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.42B 282.81% | 6.432B 18.67% | 3.404B -47.08% | 2.368B -30.44% | 2.504B 5.74% | 2.636B 5.27% | |
| EBITDA YoY % growth | N/A | N/A | N/A | 1.433B 15.10% | 1.578B 10.12% | N/A | |
| EBIT YoY % growth | N/A 1,323.01% | N/A 31.68% | N/A -0.29% | 1.417B 2.98% | 1.506B 6.28% | 1.597B 6.04% | |
| Operating Margin | N/A | N/A | N/A | 59.84% | 60.14% | 60.58% | |
| EPS YoY % growth | 1.10 52.52% | 1.50 36.00% | N/A -0.73% | 1.44 -3.22% | 1.52 5.52% | 1.61 5.90% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 0.35 | 0.35 20.35% |
| Revenue Q2Q % growth | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
0.46%
EPS Next 5 Year
1.79%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
2.21%
Revenue Next 5 Year
2.97%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BANCA MEDIOLANUM SPA / BMED.MI Forecast FAQ
What is the average price target for BANCA MEDIOLANUM SPA (BMED.MI) stock?
17 analysts have analysed BMED.MI and the average price target is 21.94 EUR. This implies a price increase of 26.86% is expected in the next year compared to the current price of 17.295.
Can you provide the upcoming earnings date for BANCA MEDIOLANUM SPA?
BANCA MEDIOLANUM SPA (BMED.MI) will report earnings on 2026-05-07.
Can you provide the consensus rating for BANCA MEDIOLANUM SPA stock?
The consensus rating for BANCA MEDIOLANUM SPA (BMED.MI) is 78.8235 / 100 . This indicates that analysts generally have a positive outlook on the stock.